Market News

Unpleasant Surprise: Bluejay Diagnostics Dips in Q4 2023 Earnings

by Ron Finklestien

Updated On: March 29, 2024 1:48 am

Financial Fumble: BJDX Falls Short of EPS Projections

BJDX stock - BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q4 2023

Source: iQoncept / Shutterstock

Bluejay Diagnostics (NASDAQ:BJDX) recently unveiled its performance for Q4 of 2023.

Regrettably, Bluejay Diagnostics reported earnings per share of -$1.78, missing the analyst prediction of -68 cents.
Additionally, the company refrained from detailing any revenue for the quarter in question.

InvestorPlace Earnings operates autonomously, tapping into TradeSmith’s data to streamline coverage of quarterly financial outcomes. Viewer-friendly breakdowns involve metrics such as earnings per share and revenue alongside a company’s alignment with analyst expectations. These reports are disseminated without human intervention, ensuring our audience receives the most recent figures promptly. Should you encounter any issues or inaccuracies, please reach out via [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/bjdx-stock-earnings-bluejay-diagnostics-for-q4-of-2023/.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.